Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Journal of Ethnopharmacology|July 31, 2021
Babao Dan is a robust anti-tumor agent via inhibiting wnt/β-catenin activation and cancer cell stemnessXinxin Xie, Jinxiao Chen, Da Wo, et al.Antioxidants (Basel, Switzerland)|June 26, 2026
Rhynchophylline Protects Against Ischemic Injury Following Myocardial Infarction via Activation of the SIRT1/NRF2/FOXO3a AxisWenyue Yang, En Ma, Zihan Zhou, et al.Heliyon|December 29, 2022
Qingda granule prevents obesity-induced hypertension and cardiac dysfunction by inhibiting adverse Akt signaling activationQian Gao, En Ma, Jinxiao Chen, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 23, 2024
Resveratrol protects against myocardial ischemic injury in obese mice via activating SIRT3/FOXO3a signaling pathway and restoring redox homeostasisXi Zhu, En Ma, Yixuan Ge, et al.Journal of Cellular and Molecular Medicine|June 30, 2020
IGFBP-4 enhances VEGF-induced angiogenesis in a mouse model of myocardial infarctionDa Wo, Jinxiao Chen, Qiongyu Li, et al.Frontiers in Pharmacology|October 2, 2025
Qingda granule prevents Ang II-induced cardiac hypertrophy via inhibiting NF-κB signaling pathwayYuhang Gong, Da Wo, Canran Wang, et al.Integrative Cancer Therapies|April 20, 2023
Babao Dan Alleviates Cancer Cachexia in Mice Via Inhibiting IL-6/STAT3 Signaling PathwayZhengliang Qiu, Da Wo, Xiaomei Zhong, et al.Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Resveratrol Prevents Breast Cancer Metastasis by Inhibiting Wnt/β-Catenin Pathway-Mediated Epithelial-Mesenchymal TransitionXue Fang, En Ma, Runshu Wang, et al.Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Qishen Yiqi Dropping Pills Protect Against Myocardial Infarction in Mice via Activating SIRT3/FOXO3a Signaling PathwayCanran Wang, Da Wo, Yi Huang, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 5, 2022
Huoxin pill prevents excessive inflammation and cardiac dysfunction following myocardial infarction by inhibiting adverse Wnt/β‑catenin signaling activationJia He, Da Wo, En Ma, et al.Pageof 3